Profile of:

Khalid Alnaqbi

• Dr. Khalid Alnaqbi is a Consultant Rheumatologist and Chief of Rheumatology at Tawam Hospital (UAE), and Physician Lead of Rheumatology Committee of SEHA Medical Council. • Adjunct Associate Professor, UAE University • Vice President of Emirates Medical Association • Graduated from the College of Medicine and Health Sciences, UAE University. • Completed post-graduate residency training at the University of Toronto in Internal Medicine, Rheumatology, and Spondyloarthritis Fellowship. • Holds multiple board certifications (American and Canadian Boards in Internal Medicine and Rheumatology, Clinician Investigator Board, Patient Safety and Quality Improvement Program). • Published in peer-reviewed journals and wrote a book chapter on (Diagnosis of Ankylosing Spondylitis). Dr. Alnaqbi is a journal reviewer in prestigious journals. • Launched Spondyloarthritis Program: received the American accreditation (CCPC) which is the first of accreditation outside the USA. • Fellow of the American College of Physicians (FACP), a Fellow of the American College of Rheumatology (FACR), and a Fellow of the Royal College of Physicians & Surgeons of Canada (FRCPC). • Member of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). • Speaker in numerous national and international meetings. • Active on social media: Twitter, Instagram, LinkedIn • Co-investigator at Al Ain hospital of a multi-center observational study on [Patients with axial spondyloaRthritis: Multi-cOuntry Registry OF (PROOF) clinical characteristics, including radiographic progression, and burden of disease over 5 years in real-life setting]: August 2015 – August 2020 • Alnaqbi KA, Al Araimi T, Al Emadi S, Al Rayyes H, Saleh K, Bashir K, and Baraliakos X. Challenges in referral, diagnosis and management of patients with axial spondyloarthritis [abstract]. J Rheum Dis 2021:28 (S1): 286 • Alnaqbi KA, Barquin P, Bellanger A, Brill A, Castañeda Hernández G, Clopés Estela A, Delgado Sánchez O, García Alfonso P, Gyger P, Heinrich D, Hezard G, Kakehasi A, Koehn C, Mariotte O, Pérez Tapia SM, Pistollato M, Mennini F, Ross-Stewart K, Saada R, Sasaki T, Simoens S, Tambassis G, Thill M, Werutsky G, Wilsdon T. 2022. Biosimilars: A global roadmap for policy Sustainability • Alkindi F, Al Nokhatha S, Alseiari K, Alnaqbi KA. Reactive hip arthritis and avascular necrosis post severe COVID-19 infection: Case report and review of the literature. EMJ. 2022;7[1]:48-55. DOI/10.33590/emj/21-00261. https://doi.org/10.33590/emj/21- 00261 • Passalent L, Hawke C, Lawson DO, Omar A, Alnaqbi KA, Wallis D, Steinhart H, Silverberg M, Wolman S, Derzko-Dzulynsky L, Haroon N, Inman RD. Advancing Early Identification of Axial Spondyloarthritis: An Interobserver Comparison of Extended Role Practitioners and Rheumatologists. J Rheumatol. 2020 Apr;47(4):524-530. doi: 10.3899/jrheum.180787. Epub 2019 May 1. PMID: 31043543.